In prostate cancer, MEIS2 shows a negative role in the regulation of a constitutive intrinsic inflammatory signaling circuit that promotes castration‐resistant prostate cancer (CRPC) development. The gene discussed is MEIS2; the disease is Familial prostate cancer.